Historical Archive
-
Antitrust. The pharmaceutical sector remains among the most sanctioned. Abuse and instrumental use of the patent
This is what emerged from the annual report of the Authority for competition and the market presented today in Parliament. The Guarantor is…
Leggi » -
US Court, companies citable for 'pay-for-delay' agreements
Pharmaceutical companies can be sued for paying rival companies to delay getting to market…
Leggi » -
Di Iorio (Naples): lack of drugs, poor image and service
The shortage of drugs in the pharmacies of Naples impoverishes the image of the pharmacy in the eyes of the patient and makes the…
Leggi » -
-
The generic drug is no savings for the Irish
by Letizia Orlandi – 06.18.2013 Generic medicines are expensive for the Irish. Forced to pay three times as much…
Leggi » -
Generic drugs. Rasi and Mandelli on the Teva case: "No danger"
After the death of a 90-year-old in France days ago due to the presence of a sleeping pill in a box…
Leggi » -
Drugs, doctors and patients prefer branded ones to generics
by Roberto Turno Article Chronology18 June 2013 Crisis or no crisis, according to doctors, Italians prefer designer drugs…
Leggi » -
Ega, sustainable EU healthcare only by focusing on generics and biosimilars
"E’ fondamentale che le aziende produttrici di generici e biosimilari, che assicurano posti di lavoro tecnicamente qualificati e know how,…
Leggi » -
Safety warnings from Aifa on four medicines
L’Agenzia italiana del farmaco ha recepito 4 avvertimenti, relativi alla sicurezza di altrettanti medicinali, varati dal Prac, il comitato di…
Leggi » -
Summit in Confindustria for Menarini, Rifondazione asks for a report on the meeting
In città mercoledì 19 giugno Rsu, proprietà e sindacati. I consiglieri provinciali Calò e Verdi interrogano la Provincia 17/06/2013 –…
Leggi »